ArticleJTCVS open2022

Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non-small cell lung cancer.

Seth B Krantz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.